Low-dose CD20 Monoclonal Antibody Injection in Preemptive Treatment of PTLD in Patients With EBV-HLH/CAEBV
Clinical trial NCT05258136 · UNKNOWN
Trial details
- NCT number
- NCT05258136
- Sponsor
- Beijing Friendship Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2023-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.